Gain Therapeutics, Inc.
NASDAQ:GANX · NASDAQ Global Market
+$0.06 today
Vol 0.50M · Avg 0.64M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+11.24%
Period High
$4.18
Period Low
$1.44
Latest
$1.88
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Adagene Inc.
NASDAQ:ADAG
$138.36M
Fortress Biotech, Inc.
NASDAQ:FBIO
$100.82M
OS Therapies Incorporated
AMEX:OSTX
$81.06M
Adicet Bio, Inc.
NASDAQ:ACET
$75.91M
XBiotech Inc.
NASDAQ:XBIT
$71.65M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$69.75M
TScan Therapeutics, Inc.
NASDAQ:TCRX
$55.81M
Nutriband Inc.
NTRB
$38.41M
CervoMed Inc.
CRVO
$37.87M
Lite Strategy, Inc.
LITS
$29.34M
What is the latest GANX filing?
The latest filing shown is 8-K dated May 26, 2026.
How many recent filings does GANX have?
Intrinsic Alpha currently shows 20 recent filings for GANX.
Explore More
Continue the stock analysis
Jump to another research area for this company.